Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Pediatric Nephrology
Erschienen in: Pediatric Nephrology 8/2014

01.08.2014 | Educational Review

Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children

verfasst von: Kiran Upadhyay, Richard N. Fine

Erschienen in: Pediatric Nephrology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Hematopoietic stem cell transplantation (HSCT) is an accepted treatment modality for various malignant and non-malignant disorders of the lympho-hematopoietic system. Patient survival rate has increased significantly with the use of this procedure. However, with the increase in disease-free patient survival rates, complications including various organ toxicities are also common. Kidney, liver, lung, heart, and skin are among those solid organs that are commonly affected and frequently lead to organ dysfunction and eventually end-organ disease. Conservative measures may or may not be successful in managing the organ failure in these patients. Solid organ transplantation has been shown to be promising in those patients who fail conservative management. This review will summarize the causes of solid organ (kidney, liver, and lung) dysfunction and the available data on transplantation of these solid organs in post-HSCT recipients.
Literatur
1.
2.
3.
Zager RA (1994) Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443–1458PubMedCrossRef
4.
Parikh CR, Coca SG (2006) Acute renal failure in hematopoietic cell transplantation. Kidney Int 69:430–435PubMedCrossRef
5.
Paquette RL, Tran L, Landaw EM (1998) Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 22:351–357PubMedCrossRef
6.
Fink JC, Cooper MA, Burkhart KM, McDonald GB, Zager RA (1995) Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced “hepatorenal syndrome”. J Am Soc Nephrol 6:1655–1660PubMed
7.
Spitzer TR (2001) Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27:893–898PubMedCrossRef
8.
Cahill RA, Spitzer TR, Mazumder A (1996) Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18:177–184PubMed
9.
Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffe FI, Locascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB (2011) Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant 11:1464–1477PubMedCentralPubMedCrossRef
10.
Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101PubMedCentralPubMedCrossRef
11.
Herget-Rosenthal S, Uppenkamp M, Beelen D, Kohl D, Kribben A (2000) Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation. Nephron 84:136–141PubMedCrossRef
12.
VanWhy SK, Friedman AL, Wei LJ, Hong R (1991) Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7:383–388
13.
Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1-year post-BMT. Bone Marrow Transplant 22:559–564PubMedCrossRef
14.
Clajus C, Hanke N, Gottlieb J, Stadler M, Weismüller TJ, Strassburg CP, Bröcker V, Bara C, Lehner F, Drube J, Kielstein JT, Schwarz A, Gueler F, Haller H, Schiffer M (2012) Renal comorbidity after solid organ and stem cell transplantation. Am J Transplant 12:1691–1699PubMedCrossRef
15.
Ludwig P, Karim K, Felix R, Joachim M (2003) Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 18:623–635
16.
Ileri T, Ertem M, Ozcakar ZB, Ince EU, Biyikli Z, Uysal Z, Ekim M, Yalcinkaya F (2010) Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 14:138–144PubMedCrossRef
17.
Lane PH, Mauer SM, Blazar BR, Ramsa Y, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13:613–617PubMed
18.
Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW (2002) Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62:566–573PubMedCrossRef
19.
Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ (1988) Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15:99–104PubMedCrossRef
20.
Cohen EP, Lawton CA, Moulder JE (1995) Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 70:217–222PubMedCrossRef
21.
Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR (2006) Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6:89–94PubMedCrossRef
22.
Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB (2007) Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39:223–229PubMedCrossRef
23.
Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE (1998) End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79:408–412PubMedCrossRef
24.
Thomas SE, Hutchinson RJ, DebRoy M, Magee JC (2004) Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 8:507–512PubMedCrossRef
25.
Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD (2008) Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 8:2378–2390PubMedCentralPubMedCrossRef
26.
Miralbell R, Bieri S, Mermillad B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz JM, Chapuis B (1996) Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 14:579–585PubMed
27.
Leiper AD (2002) Non-endocrine late complications of bone marrow transplantation. Br J Haematol 118:3–22PubMedCrossRef
28.
Kim BK, Chung KW, Sun HS, Suh JG, Min WS, Kang CS, Sim SI, Shin WS, Kim CC (2000) Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 26:193–197PubMedCrossRef
29.
Ozdogan O, Ratip S, al Ahdab YA, Dane F, Ahdab HA, Imeryüz N, Tözün N (2003) Causes and risk factors for liver injury following bone marrow transplantation. J Clin Gastroenterol 36:421–426PubMedCrossRef
30.
Lee SJ, Vogelsang G, Flowers ME (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9:215–233PubMedCrossRef
31.
Frisk P, Bratteby LE, Carlson K, Lonnerholm G (2002) Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29:129–136PubMedCrossRef
32.
Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J (2001) Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27:319–327PubMedCrossRef
33.
Hale GA, Bowman LC, Rochester RJ, Benaim E, Heslop HE, Krance RA, Horwitz EM, Cunningham JM, Tong X, Srivastava DK, Handgretinger R, Jones DP (2005) Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. Biol Blood Marrow Transplant 11:912–920PubMedCrossRef
34.
Kist-Van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FC, Wolterbeek R, Bredius RG, Pauwels EK, van der Heijden AJ (2005) Long-term renal function after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 36:605–610PubMedCrossRef
35.
Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC (1993) Clinical course of late-onset bone marrow transplant nephropathy. Nephron 64:626–635PubMedCrossRef
36.
Imai H, Oyama Y, Miura AB, Endoh M, Sakai H (2000) Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 36:474–480PubMedCrossRef
37.
Lonnerholm G, Carlson K, Bratteby LE, Backlund L, Hagberg H, Rikner G, Smedmyr B, Oberg G, Simonsson B (1991) Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 8:129–134PubMed
38.
Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP (1999) Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 13:330–335PubMedCrossRef
39.
Leblond V, Sutton L, Jacquiaud C, Item C, Sadoun R, Jaudon MC, Raymond F, Jacobs C, Deray G (1995) Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 6:1661–1665PubMed
40.
Lawton CA, Cohen EP, Barberderus SW, Murray KJ, Ash RC, Casper JT, Moulder JE (1991) Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67:2795–2800PubMedCrossRef
41.
Schriber JR, Herzig GP (1997) Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 34:126–133PubMed
42.
Hamawi K, De Magalhaes-Silverman M, Bertolatus JA (2003) Outcomes of renal transplantation following bone marrow transplantation. Am J Transplant 3:301–305PubMedCrossRef
43.
Juncos LI, Cornejo JC, Gomes J, Baigorria S, Juncos LA (1997) Abnormal endothelium-dependent responses in early radiation nephropathy. Hypertension 30:672–676PubMedCrossRef
44.
Esiashvili N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH, Paulino AC (2009) Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90:242–246PubMedCrossRef
45.
Antignac C, Gubler MC, Leverger G, Broyer M, Habib R (1989) Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 35:1336–1344PubMedCrossRef
46.
Przepiorka D, Anderlini P, Saliba R, Cleary K, Mehra R, Khouri I, Huh YO, Giralt S, Braunschweig I, van Besien K, Champlin R (2001) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98:1695–1701PubMedCrossRef
47.
Lin J, Markowitz GS, Nicolaides M, Hersdorffer CS, Appel GB, Dágati VD, Savage DG (2001) Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 21:351–356PubMedCrossRef
48.
Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Aljama-Garcia P, Lopez-Rubio F, Martinez-Guibelalde F, Fornes-Torres G, Rojas-Contreras R (1988) Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplantation 3:357–362PubMed
49.
Hiesse C, Goldschmidt E, Santellia G, Charpentier B, Machouer D, Fries D (1988) Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 11:188–191PubMedCrossRef
50.
Vischini G, Niscola P, Ferrannini M, Cupelli L, Tendas A, Scaramucci L, Giovannini M, Dentamaro T, de Fabritiis P, Palumbo R (2012) Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature. G Ital Nefrol 29:394–403PubMed
51.
Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B (2006) Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 1:685–694PubMedCrossRef
52.
Walker JV, Morich D, Anasetti C (1995) Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis 26:532–534PubMedCrossRef
53.
Perrotta S, Conte ML, La Manna A, Indolfi P, Rossi F, Locatelli F, Nobili B (2005) Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. Haematologica 90 Suppl:ECR31
54.
Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J (1999) Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 23:99–101PubMedCrossRef
55.
Akar H, Keven K, Celebi H, Orhan D, Nerzigoglu G, Erbay B, Tulunay O, Ozcan M, Ertürk S (2002) Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol 15:79–82PubMed
56.
Kimura M, Wakabayashi T, Sata T, Mohri H, Shimada K (1990) Membranous glomerulonephritis as an outstanding feature of renal lesions in autoimmune graft-vs-host F1 mice. Jpn J Exp Med 60:235–239PubMed
57.
Seconi J, Watt V, Ritchie DS (2003) Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 32:447–450PubMedCrossRef
58.
Bunin N, Guzikowski V, Rand ER, Goldfarb S, Baluarte J, Meyers K, Olthoff KM (2010) Solid organ transplants following hematopoietic stem cell transplant in children. Pediatr Transplant 14:1030–1035PubMedCrossRef
59.
Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL (1991) Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114:954–955PubMedCrossRef
60.
Dey B, Sykes M, Spitzer T (1998) Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore) 77:355–369CrossRef
61.
Helg C, Chapius B, Bolle JF, Morel P, Salomon D, Roux E, Antonioli V, Jeannet M, Leski M (1994) Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58:1320–1421
62.
Jankowski RA, Ildstad ST (1997) Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. Hum Immunol 52:155–161PubMedCrossRef
63.
Cosimi AB, Sachs DH (2004) Mixed chimerism and transplantation tolerance. Transplantation 77:943–946PubMedCrossRef
64.
65.
Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST (2013) Evolving approaches of hematopoietic stem-cell based therapies to induce tolerance to organ transplants: the long road to tolerance. Clin Pharmacol Ther 93:36–45PubMedCentralPubMedCrossRef
66.
Maeng H, Lee JH, Cheong JW, Lee ST, Hahn JS, Ko YW, Min YH (2004) Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation. Int J Hematol 79:501–504PubMedCrossRef
67.
Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW (1996) Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 2:225–232PubMedCrossRef
68.
Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R, Stone M, Klintmalm G (2003) Liver transplant-associated graft-versus-host disease. Transplantation 75:118–126PubMedCrossRef
69.
McDonald G, Sharma P, Matthews D, Shulman H, Thomas E (1985) The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 39:603–608PubMedCrossRef
70.
Richardson P, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100:4337–4343PubMedCrossRef
71.
Barshes N, Myers G, Lee D, Karpen SJ, Lee TC, Patel AJ, Finegold M, Goss JA (2005) Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data. Liver Transpl 5:525–531CrossRef
72.
Hadzic N, Height S, Ball S, Rela M, Heaton ND, Veys P, Mieli-Vergani G (2008) Evolution in the management of acute liver failure-associated aplastic anemia in children: a single center experience. J Hepatol 48:68–73PubMedCrossRef
73.
Andreoni KA, Lin JI, Groben PA (2004) Liver transplantation 27 years after bone marrow transplantation from the same living donor. N Engl J Med 350:2624–2625PubMedCrossRef
74.
Granot E, Loewenthal R, Jakobovich E, Gazit E, Sokal E, Reding R (2012) Living related liver transplant following bone marrow transplantation from same donor: long-term survival without immunosuppression. Pediatr Transplant 16:E1–E4PubMedCrossRef
75.
Englert C, Ganschow R (2012) Liver transplantation in a child with liver failure due to chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from the same unrelated living donor. Pediatr Transplant 16:E325–E327PubMedCrossRef
76.
Urban C, Deutschmann A, Kerbl R, Lackner H, Schwinger W, Königsrainer A, Margreiter R (2002) Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 30:535–537PubMedCrossRef
77.
Afessa B, Litzow MR, Tefferi A (2001) Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 28:425–434PubMedCrossRef
78.
Soubani AO, Uberti JP (2007) Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 29:1007–1019PubMedCrossRef
79.
Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Litzow MR (1998) Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 100:680–687PubMedCrossRef
80.
Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9:657–666PubMedCrossRef
81.
Yoshihara S, Yanik G, Cooke K, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13:749–759PubMedCrossRef
82.
Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF (1995) Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 8:551–558PubMed
83.
Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y, Nishimura M (2003) Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 102:4236–4242PubMedCrossRef
84.
Chan CK, Hyland RH, Hutcheon MA (1990) Pulmonary complications following bone marrow transplantation. Clin Chest Med 11:323–332PubMed
85.
Svendsen UG, Aggestrup S, Heilmann C, Jacobsen N, Koch C, Larsen B, Svejgaard A, Thisted B, Petterson G (1995) Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. Eur Respir J 8:334–337PubMedCrossRef
86.
Shiraishi T, Hiratsuka M, Munakata M, Higuchi T, Makihata S, Yoshinaga Y, Yamamoto S, Iwasaki A, Yasumoto M, Hamada T, Higa K, Kuraki T, Watanabe K, Morishige N, Tashiro T, Nabeshima K, Kawahara K, Okabayashi K, Yasunaga H, Shirakusa T (2007) Living-donor single-lobe lung transplantation for bronchiolitis obliterans in a 4-year-old boy. J Thorac Cardiovasc Surg 134:1092–1093PubMedCrossRef
87.
Heath JA, Kurland G, Spray TL, Kernan NA, Small TN, Brochstein JA, Gillio AP, Boklan J, O’Reilly RJ, Boulad F (2001) Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. Transplantation 72:1986–1990PubMedCrossRef
88.
Pechet TV, de le Morena M, Mendeloff EN, Sweet SC, Shapiro SD, Huddleston CB (2003) Lung transplantation in children following treatment for malignancy. J Heart Lung Transplant 22:154–160PubMedCrossRef
89.
Yousef S, Benden C, Boyer D, Elidemir O, Frischer T, Goldfarb S, Lopez-Mitnik G, Mallory G, Visner G, Westall G, Schecter MG (2013) Lung transplantation in children following bone marrow transplantation: a multi-center experience. Pediatr Transplant 17:231–236PubMedCrossRef
90.
Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M (2007) Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 26:681–686PubMedCrossRef
91.
Gascoigne A, Corris P (1994) Lung transplants in patients with prior bone marrow transplants. Chest 105:327PubMedCrossRef
92.
Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He GW, Yim A (2006) Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg 30:846–851PubMedCrossRef
93.
Okumura H, Ohtake S, Ontachi Y, Ozaki J, Shimadoi S, Waseda Y, Kondo Y, Yamazaki H, Takami A, Yasui M, Date H, Nakao S (2007) Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 86:369–373PubMedCrossRef
94.
Kapoor S, Kurland G, Jakacki R (2000) Recurrent medulloblastoma following pediatric double-lung transplant. J Heart Lung Transplant 19:1011–1013PubMedCrossRef
95.
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919PubMedCentralPubMedCrossRef
96.
Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931–940PubMedCrossRef
Metadaten
Titel
Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children
verfasst von
Kiran Upadhyay
Richard N. Fine
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 8/2014
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-013-2587-4

Weitere Artikel der Ausgabe 8/2014

Pediatric Nephrology 8/2014 Zur Ausgabe

Publisher's Erratum

Erratum to: Pediatric Nephrology, Volume 29, Issue 5 (2014)

Original Article

Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings

Review

Is rituximab effective in childhood nephrotic syndrome? Yes and no

Educational Review

Assessment of nutritional status in children with chronic kidney disease and on dialysis

Original Article

Evaluation of quality of life by young adult survivors of severe chronic kidney disease in infancy

Letter to the Editor

CD80 and suPAR: Diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?

Neu im Fachgebiet Pädiatrie

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise